APL Healthcare`s Unit-IV Classified As VAI By The USFDA
14 Mar 2026 //
INDPHARMAPOST
FDA Issues Form 483 with 5 Observations to Aurobindo Unit
18 Dec 2025 //
ECONOMICTIMES
Fire at Subsidiary Temporarily Impact Aurobindo Pharma Production
19 Sep 2025 //
ECONOMICTIMES

Market Place
Sourcing Support